HIGH-DOSE CISPLATIN IN HYPERTONIC SALINE - REDUCED TOXICITY OF A MODIFIED DOSE SCHEDULE AND CORRELATION WITH PLASMA PHARMACOKINETICS - A NORTHERN CALIFORNIA ONCOLOGY GROUP PILOT-STUDY IN NON-SMALL-CELL LUNG-CANCER

被引：70
作者：
GANDARA, DR
DEGREGORIO, MW
WOLD, H
WILBUR, BJ
KOHLER, M
LAWRENCE, HJ
DEISSEROTH, AB
GEORGE, CB
机构：
[1] NO CALIF ONCOL GRP,PALO ALTO,CA
[2] UNIV CALIF DAVIS,DIV HEMATOL ONCOL,DAVIS,CA 95616
[3] UNIV CALIF SAN FRANCISCO,CANC RES INST,SAN FRANCISCO,CA 94143
[4] LETTERMAN ARMY INST RES,SERV HEMATOL ONCOL,SAN FRANCISCO,CA 94129
[5] UNIV CALIF SAN FRANCISCO,DIV HEMATOL ONCOL,SAN FRANCISCO,CA 94143
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 12期
关键词：
D O I：
10.1200/JCO.1986.4.12.1787
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1787 / 1793
页数：7
相关论文
共 23 条
[1]   A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY WITH IMPROVED SELECTIVITY FOR CISPLATIN AND ACTIVE PLATINUM(II) COMPLEXES IN PLASMA ULTRAFILTRATE [J].
ANDREWS, PA ;
WUNG, WE ;
HOWELL, SB .
ANALYTICAL BIOCHEMISTRY, 1984, 143 (01) :46-56
[2]  
BRUCKNER HW, 1981, GYNECOL ONCOL, V12, P61
[3]   CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN [J].
CORDEN, BJ ;
FINE, RL ;
OZOLS, RF ;
COLLINS, JM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) :38-41
[4]  
CROWLEY T, 1985, P AM ASSOC CANC RES, V26, P156
[5]  
DEGREGORIO MW, 1985, CANCER CHEMOTH PHARM, V15, P183
[6]  
DEGREGORIO MW, 1985, CANCER TREAT REP, V69, P1441
[7]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[8]   CURRENT CONCEPTS IN CANCER - ROLE OF CIS-PLATINUM IN SOLID-TUMOR THERAPY [J].
EINHORN, LH ;
WILLIAMS, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) :289-291
[9]  
HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO
[10]  
2-J
123